Talk:Budesonide

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine: Translation Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Translation task force (assessed as High-importance).

COVID-19 Low‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Budesonide.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic.

Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page.

FDA category B or C

I've found conflicting reports of the FDA pregnancy category for this drug. Please see reference: http://www.rxlist.com/cgi/generic/budesonide_wcp.htm

Thank you —Preceding unsigned comment added by 76.177.33.33 (talk) 22:36, 9 September 2007 (UTC)[reply]

The FDA drug label information says that it is Category C, so at least the budesonide formulation sold by GlaxoSmithKline is class C. Pgk1 00:18, 18 October 2007 (UTC)[reply]

I just did some research on this today. According to this FDA report it is pregnancy class B for the nasal inhalant form: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021949s004lbl.pdf — Preceding unsigned comment added by 98.192.147.255 (talk) 17:12, 10 October 2011 (UTC)[reply]

Misuse Section

The misuse section seems to be more about misuse of Medicare/Insurance fraud than misuse of this particular product. Maybe it should be removed? Or re-labelled "In the news" or something. — Preceding unsigned comment added by 124.148.172.201 (talk) 08:50, 11 April 2012 (UTC)[reply]

I don't think it's important enough to meet WP:WEIGHT or keep in the article. Does anybody have a reason to keep it in? --Nbauman (talk) 06:15, 4 September 2012 (UTC)[reply]

Use section

The 'Use' section does not mention the fact that the drug is also used to treat rhinitis even though this is clearly mentioned in the introductory paragraph of the article. — Preceding unsigned comment added by Belnac (talk • contribs) 10:15, 6 November 2013 (UTC)[reply]

Footnote 17 is a broken link, please fix

External links modified

Hello fellow Wikipedians,

I have just modified 2 external links on Budesonide. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at {{Sourcecheck}}).

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 18 January 2022).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 08:05, 10 November 2016 (UTC)[reply]

eosinophilic oesophagitis

I am not a wikipedia editor. Maybe you want to add informations about eosinophilic oesophagitis and Jorveza.

https://en.wikipedia.org/wiki/Eosinophilic_esophagitis

https://www.ema.europa.eu/en/medicines/human/EPAR/jorveza

https://www.medicines.org.uk/emc/product/9446/smpc

https://www.drfalkpharma-benelux.eu/sites/www.drfalkpharma-benelux.nl/files/01-2018-BNL%20Press%20release%20Jorveza.pdf — Preceding unsigned comment added by 37.49.65.123 (talk) 09:07, 1 June 2019 (UTC)[reply]

Pharmacokinetics section

In this section we have

"Distribution: 2.2-3.9 L/kg"

What is that actually supposed to say? John G Hasler (talk) 23:15, 9 July 2021 (UTC)[reply]